獸醫感染疾病診斷市場規模、佔有率和成長分析（按感染疾病類型、技術、動物類型、最終用戶和地區分類）—2026-2033年產業預測

預計到 2024 年，獸醫感染疾病診斷市場規模將達到 21.8 億美元，到 2025 年將達到 23.8 億美元，到 2033 年將達到 47.3 億美元，在預測期（2026-2033 年）內複合年成長率為 9%。

獸醫感染疾病診斷市場對於快速有效地診斷動物疾病至關重要，從而透過加強預防、控制和治療措施來改善動物健康。全球化和畜牧業實踐的改變等因素導致感染疾病日益流行，推動了對可靠診斷解決方案的需求。然而，高成本、熟練專業人員短缺以及某些地區基礎設施不足等挑戰可能會阻礙市場准入和應用。儘管存在這些障礙，但快速檢測和就地檢驗等技術進步正在創造許多機會。此外，人們對通用感染疾病的認知不斷提高，以及「同一健康」理念的倡導，凸顯了互聯互通的衛生系統的重要性，這將推動獸醫感染疾病診斷領域的成長，從而改善全球動物和公眾健康。

獸醫感染疾病診斷市場促進因素

人們對動物健康和福利的日益關注是推動獸醫感染疾病診斷市場發展的關鍵因素。隨著寵物飼主和畜牧養殖戶的知識水平不斷提高，他們積極尋求先進的診斷工具和服務，以便及早發現並有效管理感染疾病。這種日益增強的意識凸顯了監測動物健康的重要性，尤其是在近期全球健康挑戰的背景下，這些挑戰更加凸顯了強大的診斷能力對於識別和應對通用感染疾病的重要性。因此，對可靠診斷方法的不斷成長的需求持續顯著地影響著市場格局。

獸醫感染疾病診斷市場面臨的限制因素

獸醫感染疾病診斷市場面臨的主要挑戰之一是先進診斷技術和服務的高昂成本。對於小規模的獸醫診所，尤其是在資源匱乏地區，購買尖端診斷工具和設備所需的投資可能構成重大障礙。這種經濟障礙可能會限制這些先進診斷方法的普及和廣泛應用，最終阻礙整個市場的擴張。因此，成本因素在限制獸醫專業人員實施創新解決方案的能力方面起著至關重要的作用，而這些創新解決方案有望改善動物感染疾病的診斷和治療。

獸醫感染疾病診斷市場趨勢

就地檢驗（POC​​T）的普及是獸醫感染疾病診斷市場的一大趨勢，反映出獸醫診療實踐正朝著即時快速診斷的方向發展。這些高度便攜且易於操作的POCT設備使獸醫能夠在現場進行檢測，從而實現即時決策並改善患者預後。這一趨勢不僅簡化了診斷流程，還透過減少對中心實驗室的依賴，提高了獸醫診療的效率。因此，市場正在朝著優先考慮能夠及時干預動物感染疾病管理的創新解決方案的方向發展，凸顯了對便捷診斷技術的日益成長的需求。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球獸醫感染疾病診斷市場規模（依感染疾病類型和複合年成長率分類）（2026-2033 年）

• 細菌感染疾病
• 病毒感染疾病
• 寄生蟲感染疾病
• 其他感染疾病

全球獸醫感染疾病診斷市場規模（依技術及複合年成長率分類）（2026-2033 年）

• 免疫診斷方法
  • 橫向流動化驗
  • ELISA檢測
• 其他免疫診斷技術
• 分子診斷
  • 聚合酵素鏈鎖反應（PCR）檢測
  • 微陣列
• 其他分子診斷測試
• 其他獸醫診斷技術

全球獸醫感染疾病診斷市場規模（按動物類型分類）及複合年成長率（2026-2033 年）

• 伴侶動物
  • 狗
  • 貓
  • 馬
• 其他伴侶動物
• 食用動物
  • 牛
  • 豬
  • 家禽
  • 其他食用動物

全球獸醫感染疾病診斷市場規模（按最終用戶分類）及複合年成長率（2026-2033 年）

• 標準與檢驗組織
• 獸醫檢查室和動物醫院
• 照護現場/院內檢測
• 研究機構和大學

全球獸醫感染疾病診斷市場規模（按地區分類）及複合年成長率（2026-2033 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• IDEXX Laboratories, Inc.（US）
• Zoetis, Inc.（US）
• Thermo Fisher Scientific, Inc.（US）
• Virbac（France）
• bioMerieux SA（France）
• Heska Corporation（US）
• NEOGEN Corporation（US）
• QIAGEN NV（Netherlands）
• Randox Laboratories Ltd.（UK）
• Agrolabo S.pA.（Italy）
• Bio-Rad Laboratories（US）
• Bionote, Inc.（South Korea）
• Biogal Galed Labs（Israel）
• BioChek（Netherlands）
• Biopanda Reagents（UK）
• URIT Medical Electric Co. Ltd.（China）
• MEGACOR Diagnostik GmbH（Germany）
• Fassisi GmbH（Germany）
• Alvedia（France）
• SKYER, Inc.（South Korea）

結論與建議

Veterinary Infectious Disease Diagnostics Market size was valued at USD 2.18 Billion in 2024 and is poised to grow from USD 2.38 Billion in 2025 to USD 4.73 Billion by 2033, growing at a CAGR of 9% during the forecast period (2026-2033).

The veterinary infectious disease diagnostics market is essential for the timely and effective diagnosis of animal diseases, enhancing prevention, control, and treatment measures that lead to better health outcomes. The increasing prevalence of infectious diseases, driven by factors such as globalization and changing husbandry practices, heightens the demand for reliable diagnostic solutions. However, challenges such as high costs, lack of skilled professionals, and inadequate infrastructure in certain regions can hinder market access and implementation. Despite these obstacles, opportunities abound through technological advancements, including rapid and point-of-care tests. Additionally, the rising awareness of zoonotic diseases and the One Health approach underline the importance of interconnected health systems, promoting growth in the veterinary infectious disease diagnostics sector for improved animal and public health globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Veterinary Infectious Disease Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Veterinary Infectious Disease Diagnostics Market Segments Analysis

Global Veterinary Infectious Disease Diagnostics Market is segmented by Infection Type, Technology, Animal Type, End User and region. Based on Infection Type, the market is segmented into Bacterial Infections, Viral Infections, Parasitic Infections and Other Infections. Based on Technology, the market is segmented into Immunodiagnostics, Other immunodiagnostic technologies, Molecular Diagnostics, Other molecular diagnostic tests and Other Veterinary Diagnostic Technologies. Based on Animal Type, the market is segmented into Companion Animals, Other companion animals and Food Producing Animals. Based on End User, the market is segmented into Reference Laboratories, Veterinary Laboratories and Clinics, Point of Care / In House Testing and Research Institutes and Universities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Veterinary Infectious Disease Diagnostics Market

The rising consciousness regarding animal health and welfare is a crucial factor propelling the veterinary infectious disease diagnostics market. As pet owners and livestock producers become more informed, they are actively pursuing advanced diagnostic tools and services to facilitate the early detection and efficient management of infectious diseases. This heightened awareness underscores the importance of monitoring animal health, especially in light of recent global health events that have emphasized the necessity for strong diagnostic capabilities to identify and address potential zoonotic diseases. Consequently, this increasing demand for reliable diagnostics continues to shape the market landscape significantly.

Restraints in the Veterinary Infectious Disease Diagnostics Market

A notable challenge facing the veterinary infectious disease diagnostics market is the high expense linked to advanced diagnostic technologies and services. The investment required for implementing state-of-the-art diagnostic tools and equipment can be prohibitive, particularly for smaller veterinary practices or clinics in under-resourced areas. This financial barrier may restrict the availability and use of these sophisticated diagnostic methods, ultimately impeding overall market expansion. As a result, the cost factor plays a crucial role in limiting the ability of veterinary professionals to adopt innovative solutions that could enhance the diagnosis and treatment of infectious diseases in animals.

Market Trends of the Veterinary Infectious Disease Diagnostics Market

The Veterinary Infectious Disease Diagnostics market is witnessing a significant trend towards the adoption of point-of-care testing (POCT), reflecting a shift towards real-time, rapid diagnostic capabilities in veterinary settings. These portable and user-friendly POCT devices empower veterinarians to conduct on-site tests, leading to immediate decision-making and improved patient outcomes. This trend not only streamlines the diagnostic process but also enhances the efficiency of veterinary care by reducing reliance on centralized laboratory facilities. Consequently, the market is evolving to prioritize innovative solutions that facilitate timely interventions in infectious disease management for animals, underscoring a growing demand for accessible diagnostic technology.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Veterinary Infectious Disease Diagnostics Market Size by Infection Type & CAGR (2026-2033)

• Market Overview
• Bacterial Infections
• Viral Infections
• Parasitic Infections
• Other Infections

Global Veterinary Infectious Disease Diagnostics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Immunodiagnostics
  • Lateral flow assays
  • ELISA tests
• Other immunodiagnostic technologies
• Molecular Diagnostics
  • Polymerase chain reaction (PCR) tests
  • Microarrays
• Other molecular diagnostic tests
• Other Veterinary Diagnostic Technologies

Global Veterinary Infectious Disease Diagnostics Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Companion Animals
  • Dogs
  • Cats
  • Horses
• Other companion animals
• Food Producing Animals
  • Cattle
  • Swine
  • Poultry
  • Other food-producing animals

Global Veterinary Infectious Disease Diagnostics Market Size by End User & CAGR (2026-2033)

• Market Overview
• Reference Laboratories
• Veterinary Laboratories and Clinics
• Point of Care / In House Testing
• Research Institutes and Universities

Global Veterinary Infectious Disease Diagnostics Market Size & CAGR (2026-2033)

• North America (Infection Type, Technology, Animal Type, End User)
  • US
  • Canada
• Europe (Infection Type, Technology, Animal Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Infection Type, Technology, Animal Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Infection Type, Technology, Animal Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Infection Type, Technology, Animal Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• IDEXX Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heska Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NEOGEN Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agrolabo S.pA. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionote, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogal Galed Labs (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioChek (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biopanda Reagents (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• URIT Medical Electric Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEGACOR Diagnostik GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fassisi GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alvedia (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SKYER, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations